The results of GEPIA showed (Figure 5E) that the expression levels of CCT6A and FAP were increased in the tumor tissues of GC patients, and the expression levels of ZFP36 and TP53I3 were decreased in the tumor tissues of GC patients. This evidence concerns the gene CCT6A and gastric cancer.